ISCOMATRIX: a novel adjuvant for use in prophylactic and therapeutic vaccines against infectious diseases

A Baz Morelli, D Becher, S Koernig… - Journal of medical …, 2012 - microbiologyresearch.org
The ISCOMATRIX adjuvant has antigen delivery and presentation properties as well as
immunomodulatory capabilities, which combine to provide enhanced and accelerated …

[HTML][HTML] Metabolic adaptation to tissue iron overload confers tolerance to malaria

R Gozzelino, BB Andrade, R Larsen, NF Luz… - Cell host & …, 2012 - cell.com
Disease tolerance is a defense strategy that limits the fitness costs of infection irrespectively
of pathogen burden. While restricting iron (Fe) availability to pathogens is perceived as a …

Liposomes containing lipid A: an effective, safe, generic adjuvant system for synthetic vaccines

CR Alving, M Rao, NJ Steers, GR Matyas… - Expert review of …, 2012 - Taylor & Francis
Liposomes containing monophosphoryl lipid A (MPLA) have previously exhibited
considerable potency and safety in human trials with a variety of candidate vaccines …

[HTML][HTML] Harnessing genomics and genome biology to understand malaria biology

SK Volkman, DE Neafsey, SF Schaffner… - Nature Reviews …, 2012 - nature.com
Malaria is an important human disease and is the target of a global eradication campaign.
New technological and informatics advancements in population genomics are being …

Profile: Nanoro health and demographic surveillance system

K Derra, E Rouamba, A Kazienga… - International journal …, 2012 - academic.oup.com
Abstract The Nanoro Health and Demographic Surveillance System (HDSS), located in the
rural centre of Burkina Faso, was established in 2009 by the Clinical Research Unit of …

Pre-erythrocytic malaria vaccines: identifying the targets

PE Duffy, T Sahu, A Akue, N Milman… - Expert review of …, 2012 - Taylor & Francis
Pre-erythrocytic malaria vaccines target Plasmodium during its sporozoite and liver stages,
and can prevent progression to blood-stage disease, which causes a million deaths each …

Unexpected fold in the circumsporozoite protein target of malaria vaccines

MB Doud, AC Koksal, LZ Mi, G Song… - Proceedings of the …, 2012 - National Acad Sciences
Circumsporozoite (CS) protein is the major surface component of Plasmodium falciparum
sporozoites and is essential for host cell invasion. A vaccine containing tandem repeats …

[HTML][HTML] A rapid and scalable density gradient purification method for Plasmodium sporozoites

M Kennedy, ME Fishbaugher, AM Vaughan… - Malaria journal, 2012 - Springer
Background Malaria remains a major human health problem, with no licensed vaccine
currently available. Malaria infections initiate when infectious Plasmodium sporozoites are …

[HTML][HTML] New approaches in antimalarial drug discovery and development: a review

ACC Aguiar, EMM da Rocha, NB de Souza… - Memorias do Instituto …, 2012 - SciELO Brasil
Malaria remains a major world health problem following the emergence and spread of
Plasmodium falciparum that is resistant to the majority of antimalarial drugs. This problem …

[HTML][HTML] Malaria in infants aged less than six months-is it an area of unmet medical need?

U D'Alessandro, D Ubben, K Hamed, SJ Ceesay… - Malaria journal, 2012 - Springer
Despite the protection provided by several factors, including maternal antibodies, the burden
of malaria in young infants may be higher than previously thought. Infants with congenital or …